Search

Tissue Additives News

New edition of our AROSURF® product portfolio

A new brochure about our AROSURF® product portfolio is now available.

Our product range covers a variety of products with specific application profiles, which address almost all needs of the tissue and fluff pulp industry: softeners and debonders under the AROSURF®, VARISOFT®, and REWOQUAT® trade names as well as softeners and pulp and paper defoamers
under the TEGOPREN® trade name.

Properties of our AROSURF® softeners and debonders are:

  • Highly substantive wet end softener/ debonders with high, medium and low debonding effect for premium to low sheet bulkiness with all qualities of feedstocks

  • Highly substantive softeners with low impact on tensile strength to achieve good machine runnability and excellent surface smoothness of the tissue

  • Substantive or non-substantive softeners for topical application on the sheet before the dryer combining moderate bulkiness with good surface softness of the tissue

  • Concentrates for converting softeners/lotions

Most of our products are food contact compliant (FDA and/or BfR) or INCI listed (cosmetic ingredients).

Contact

Matthias Kersken

Market Manager

  • Company information

    Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the Nutrition & Care, Resource Efficiency and Performance Materials segments. The company benefits from its innovative prowess and integrated technology platforms. In 2015 more than 33,500 employees generated sales of around €13.5 billion and an operating profit (adjusted EBITDA) of about €2.47 billion.

    The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,000 employees, and generated sales of around €4.9 billion in 2015.

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.